VIRIDIAN THERAPEUTICS INC

7 de ago. de 2026, 20:05 UTC

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6 de ago. de 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5 de ago. de 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4 de ago. de 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.

3 de ago. de 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reaching their lowest point despite a prior period of stability. No specific news was identified.

31 de jul. de 2026, 20:02 UTC

Viridian Therapeutics Inc's shares are lower today, breaking a trend of higher closes. Broader market factors, including rising Treasury yields, may be influencing this shift.

30 de jul. de 2026, 23:01 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, following earlier stability. Broader market uncertainty over the Federal Reserve's rate decision persists.

29 de jul. de 2026, 23:56 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Broader market uncertainty persists.

28 de jul. de 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, reversing an initial uptick amid cautious broader market sentiment and declines in technology shares.

27 de jul. de 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher, maintaining strength since Friday's close and reflecting positive momentum near the upper end of its one-month trading range.

24 de jul. de 2026, 17:36 UTC

Viridian Therapeutics shares are higher since Thursday's close, recovering from earlier lows. Broader market sentiment improved amid declining crude oil prices.

22 de jul. de 2026, 19:26 UTC

Viridian Therapeutics Inc is trading higher during Wednesday's session, recovering from earlier lows despite the broader market's mixed performance.

21 de jul. de 2026, 19:51 UTC

Viridian Therapeutics Inc shares are trading higher, reflecting strong intraday performance. The move aligns with positive sentiment in the biotechnology sector.

20 de jul. de 2026, 19:01 UTC

Viridian Therapeutics Inc is advancing in Monday's session, despite earlier pullback. No specific company news was identified to explain the price movement.